Compare RGC & EML Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RGC | EML |
|---|---|---|
| Founded | 2014 | 1858 |
| Country | Hong Kong | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Industrial Machinery/Components |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.4B | 130.2M |
| IPO Year | 2021 | N/A |
| Metric | RGC | EML |
|---|---|---|
| Price | $11.87 | $19.17 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 129.1K | 9.5K |
| Earning Date | 10-24-2025 | 11-04-2025 |
| Dividend Yield | N/A | ★ 2.26% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 1.19 |
| Revenue | N/A | ★ $258,121,226.00 |
| Revenue This Year | N/A | $1.56 |
| Revenue Next Year | N/A | $7.00 |
| P/E Ratio | ★ N/A | $18.90 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.09 | $18.49 |
| 52 Week High | $83.60 | $31.67 |
| Indicator | RGC | EML |
|---|---|---|
| Relative Strength Index (RSI) | 36.32 | 40.30 |
| Support Level | $10.33 | $19.10 |
| Resistance Level | $12.48 | $20.11 |
| Average True Range (ATR) | 1.01 | 0.51 |
| MACD | -0.05 | 0.11 |
| Stochastic Oscillator | 26.89 | 37.78 |
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.
The Eastern Co manages industrial businesses that design, manufacture, and sell engineered solutions to industrial markets. The company manages the financial, operational, and strategic performance of its businesses to increase cash generation, operating earnings, and long-term shareholder value. It operates in the United States and Other Countries and generates the majority of its revenue from the United States.